#2462 - Aaron Siri

You folded up a stack of notes like you were done studying, and it set the tone for where we went next: I used to treat vaccines like sacred science, mocked skeptics, and loved your book’s framing of vaccine belief as a kind of secular religion.

Challenging that creed triggers real cognitive dissonance, but there is a key fact most people do not know: since 1986, routine childhood vaccines have unique liability protection, so families cannot sue manufacturers for safer designs the way they can with cars, appliances, or other drugs.

Everywhere else, lawsuits and the risk of losses force safer products; with vaccines, that market pressure is missing, so problems do not surface the same way and improvements lag.

Drug approvals often rely on years of placebo-controlled follow-up because companies need to know risks before they bet the farm, but routine childhood vaccines were not licensed on that standard, which helps explain the blind spots we saw during COVID.

What about Vioxx, where internal emails showed they knew about danger yet still sold it and paid fines smaller than profits?

Companies sometimes do that math until punitive damages make it impossible, which is exactly why removing design-defect liability for vaccines is so extraordinary and suggests the products could not survive normal accountability.

If I steelman the other side, the story is that vaccines saved us from smallpox, polio, measles, and more, so they deserve special treatment and our trust.

Even assuming big benefits, essential products do not earn legal immunity; the data also show far fewer deaths from many targeted diseases in the modern era than people think, like roughly four hundred measles deaths a year before the measles shot, and flu mortality stories are muddled while some studies link flu shots with more non-flu respiratory infections.

Culturally, measles used to be a childhood nuisance, not an apocalypse, and when people die we rarely separate dying with an infection from dying of it, just like the comorbidity mess with COVID.

Measles deaths had already fallen by more than ninety-eight percent before vaccination, likely from sanitation, nutrition, and acute care, and long-term studies even associate childhood infections like measles and mumps with lower cardiovascular deaths and some cancers, which hints at evolutionary tradeoffs.

Maybe those illnesses act like a stress test that strengthens the system if you recover.

Whatever the mechanism, we should follow the evidence and align incentives so manufacturers have to make the safest possible products for babies.

Given waning maternal antibodies today, would it be safer to keep vaccinating against measles rather than let it spread to older people, and do we see opt-out groups like the Amish to study?

MMR and chickenpox shots can cut transmission, so a sudden measles wave now could hit infants and older adults due to weaker vaccine immunity, while other shots like pertussis do not block spread and can even make vaccinated people silent carriers.

It still feels odd to inject newborns for hepatitis B when the risk is mainly from specific exposures later in life.

Denmark targets hep B to babies of positive mothers and sees similar child infection rates with fewer vaccine harms, and in the United States the injury program has paid out billions under strict limits, including a case of a newborn death after a hep B shot.

When I share this at parties with people who assume the experts have it handled, the room can turn fast; do you run into that?

All the time, because many stake identity in the vaccine story or have never read primary sources, but post-COVID more people are curious, even though my posts quoting FDA and Pfizer documents were once censored.

The Twitter Files revealed government pressure to police so-called malinformation, and the whole thing got tribal fast.

The deeper shock for me was the open orders to stay home and the casual surrender of rights meant for hard times, because freedom includes choosing risk, and once you accept mandates it is cheaper to lobby for required products than to persuade.

California’s outdoor dining ban for optics, not data, showed how power clings, right down to snitch hotlines.

Bureaucracies double down to preserve credibility, which is why health agencies should recommend, not coerce, because the pattern of pressure to mandate, then censor, is the oldest road to overreach.

Fauci even framed it as making life hard enough that people comply.

That posture mirrors school mandates and efforts to erase exemptions even though most families who refuse do so after a serious adverse experience, not on a whim.

This same belief reflex shows up in climate debates and media narratives too, compounded by the fact that news depends on pharma ads while the internet is the only place to hear the other side.

Refusing to debate is anti-science, because science is never settled and advances by testing uncomfortable ideas.

Academia has hierarchy and groupthink like politics, amplified by bots and algorithms that keep people raging.

Social feeds feed confirmation bias, may even dull thinking over time, and I try to hold a nuanced view that separates which vaccines reduce spread from those that do not and what the mortality data really say.

If only staring at our phones made us smarter; my Wi-Fi is practically begging me to read a book.

Low-level exposures like wireless and other environmental insults deserve the precautionary principle, because subtle, long-term effects are the ones we miss when we assume safety by default.

Why is it crazy to suspect certain frequencies might be bad for memory or brain health?

The burden should be on those selling the exposure to show it is safe, just like you would demand proof a car is not a hazard, and that logic should apply to vaccines and new wireless tech too.

We’ve done plenty we later learned was harmful, from casual X‑rays to awarding a Nobel for lobotomy, and money still bends public perception and the news that shapes it.

Even with many people saying they knew someone hurt by COVID shots, legacy outlets kept a tight line, which shows how influence works.

Social media is like junk food for the brain, but it’s also how whistleblowers and reporters can push real stories into the light.

During COVID, alternative platforms and a few open doors on TV let contrarian medical voices be heard when most channels wouldn’t.

Politics flipped the script on vaccines overnight, and I’m glad Elon bought Twitter because it cracked the censors and let people see raw data and debate again.

Like airlines dropping mask rules after a court ruling, competition reshaped behavior fast; X did that for speech, forcing rivals to relax controls.

Once people could speak freely, pushback on gender ideology surged, and now even big outlets warn about rushing kids into medical transitions; kids are suggestible, and social contagion is real.

Hospitals and clinicians are getting sued, which is healthy pressure; the sector boomed and, like any business, then needed a steady flow of patients.

Inside big organizations, people tell themselves they’re not responsible while incentives quietly steer choices.

The market isn’t the villain so much as captured regulators; unelected agencies pump out rules while the regulated industries staff and sway them through a revolving door.

Most folks don’t realize how often top health officials land in pharma with golden parachutes, and that expectation colors decisions.

I don’t think most are scheming, but human nature responds to future paydays; even executives admit FDA staff don’t want to cross the companies they may join.

Public markets feel like a place where insiders can legally game narratives and extract value without building anything, which is nuts.

There’s making things, there’s useful finance like mortgages, and there’s pure money‑shuffling like high‑speed trading that adds nothing; markets work best with light, honest guardrails, not protection for incumbents.

Could we have had the same innovation without a stock market, instead of a system where people get rich moving money around?

Public listings turbocharge capital and give venture funds an exit, which speeds growth and broad ownership, though it brings hassle and temptations.

Finance drifts from helpful tools into baroque schemes; Madoff was outright theft, and it took a crash to expose it, but at least he went to prison.

That was a pyramid, full stop, and the system finally corrected.

It’s hard to face when data cuts against a worldview, especially on vaccines and who profits.

Vaccines are different because liability shields broke normal market checks; the infant schedule ballooned while chronic childhood illness soared, and unvaccinated groups repeatedly show far fewer chronic conditions in surveys and comparative practice data.

Are Amish autism rates low because of underdiagnosis, or is there a real signal, because severe cases weren’t common when we were kids?

Severe autism has climbed far beyond what better labeling can explain, the Amish do see mainstream doctors, and many parents across communities point to early‑life shots and MMR; when we FOIA’d CDC for studies showing first‑six‑month vaccines don’t cause autism, they couldn’t provide them.

So why do panels keep saying the autism link is thoroughly debunked?

In court and depositions, the evidence is thin despite confident messaging; even top vaccinologists conceded gaps, an Institute of Medicine review flagged a DTaP association then tossed it over controls, and AI will parrot the party line or hallucinate citations if you ask it for the science.

Are large language models trained to defend establishment narratives, or are they just echoing a web saturated with one‑sided claims; search engines already steer voters, according to Robert Epstein.

It’s likely some mix of algorithm choices and the sheer volume of well‑funded content; if you’re pharma with massive budgets, you’ll aim that firehose where models and search will drink from it.

Curation without rules is spooky; if a search engine or platform decides what people can see based on ideology, that crosses a line, and we watched versions of that after the 2016 election.

We tweaked keywords and SEO around the Paul Offit issue, and even on a small budget it seemed to change what surfaced, which shows how money and knobs can shift visibility.

Audience size is not the shield people think; one strong show or a single reporter can send crowds to a link, so sunlight still works better than quiet suppression.

During the pandemic, claims that later proved true could get you banned, and the goalposts kept moving while people mocked dissent and never owned bad calls.

That scolding breeds more distrust than any podcast could, and when agencies correct pages on sensitive topics, they should be praised for honesty instead of attacked.

Too many people defend a tribe instead of reading studies, then shout that things are debunked without ever checking the work.

I have watched experts dismiss papers they never opened; in depositions I asked for solid evidence and often got belief over data, followed by the lazy anti‑vaxxer label.

When platforms enforce a worldview, it gets nuts; thank God for alternatives, and honestly search feels like it is giving way to AI.

AI is helpful, but it can also dull thinking, so it is vital to demand primary sources and read them yourself.

I use AI like a sharp friend when I am writing, but kids using it to write full papers is a mess, and for my own sanity I never search myself or swim through hot takes.

You still grow by facing the strongest arguments against you, and I am happy to do that on the record.

What you do takes backbone; you stick to evidence, and I do not see many people eager to meet you there.

I invited Paul Offit to a structured, calm debate with equal time and slides, but he kept it online and would not show; my nine‑hour deposition of Stanley Plotkin is public proof that substance can be tested, even if videos kept getting pulled.

I offered Peter Hotez a charity donation to debate on the show, and got insults instead; if your data is strong, bring it and let it win.

Plotkin later sent me a letter saying history would credit him with saving lives and accuse me of harm; I wrote back that we both want to protect kids from disease and from product injuries, and invited real collaboration, then posted both letters so people could read them.

When you strip liability, add mandates, and let money people steer, you create awful incentives, even alongside genuinely life‑saving science.

Imagine a product with immunity from lawsuits, government promotion, and guaranteed payment; capitalism needs guardrails, but in vaccines the rails are off, and big firms look too large to cross.

I am glad you are out there explaining the data clearly; now, tell me about recording the audiobook.

Reading it was humbling; I thought I could, then my brain and mouth fell out of sync for hours.

I feel that pain doing ad reads; talking is easy until you have to hit every word, but congrats on getting it done.

It was brutal, but it is finished and up on Audible, and the book is on Amazon.

Thank you for coming; this was great, and I appreciate the work you are doing.